Clinical Trials Browser

Phase 1/2 × Neuroblastoma × ganglioside, GD2 × Clear all

NCT04637503 2020-11-19

4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma

Phase 1/2 Unknown

Gaucher Disease, Neuroblastoma